NCT06491966 Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
| NCT ID | NCT06491966 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sichuan Provincial People's Hospital |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-04-02 |
| Primary Completion | 2024-07-07 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This observational cohort study aims to compare clinical outcomes and inflammatory responses between patients with viral sepsis, specifically COVID-19-associated sepsis, and those with bacterial sepsis. Conducted at Sichuan Provincial People's Hospital, the study will retrospectively analyze data from ICU patients admitted between July 2021 and December 2023. The primary objective is to identify reliable biomarkers and diagnostic methods to improve patient outcomes through personalized diagnostic and therapeutic strategies.
Eligibility Criteria
Inclusion Criteria: 1. Patients diagnosed with sepsis according to Sepsis 3.0 criteria. 2. Patients with confirmed bacterial sepsis based on positive bacterial cultures. 3. Patients with confirmed viral sepsis, specifically COVID-19, diagnosed via RT-PCR for SARS-CoV-2 for viral group and negative for bacterial group. 4. Patients aged 18 years and older. 5. Patients admitted to the ICU during the study period. Exclusion Criteria: 1. Patients with mixed bacterial and viral infections. 2. Patients with sepsis not meeting the Sepsis 3.0 criteria. 3. Patients who received immunomodulatory therapies other than standard treatments (e.g., investigational drugs). 4. Pregnant or breastfeeding women.